FDA-OVERSIGHT › Guidance for Industry - Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring
FDA-OVERSIGHT
-
2013 EDITION
-
CURRENT
Guidance for Industry - Oversight of Clinical Investigations - A Risk-Based Approach to Monitoring
This document comes with our free Notification Service, good for the life of the document.
This document is available in either Paper or PDF format.
Document Number
10555fnl
Revision Level
2013 EDITION
Status
Current
Publication Date
Aug. 2, 2013
Page Count
22 pages